Atherosclerosis Prediction with High Sensitivity C-Reactive Protein (hs-CRP) and Related Risk Factor in Patient with Dyslipidemia
Open Access
- 14 November 2019
- journal article
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 7 (22) , 3887-3890
Abstract
BACKGROUND: Inflammation plays a major role in the initiation, destabilization and the progression of atherosclerosis. High Sensitivity C-Reactive Protein (hs-CRP) reflects active systemic inflammation and have shown to be a strong predictor of future cardiovascular events. AIM: The purpose of this study was to determine the role of High Sensitivity C-Reactive Protein (hs-CRP) independent for atherosclerosis severity prediction and to find out which factors largely is affecting hs-CRP level in dyslipidemia patient. METHODS: A total of 388 patients (267 dyslipidemia, 121 controls) were enrolled in this study. We investigated whether plasma hs-CRP is associated with atherosclerosis severity that was quantified by ankle-brachial index (ABI) and Doppler ultrasound. Related risk factor that influence hs-CRP levels in patients with dyslipidemia included determination of age, gender, diabetes, smoking, hypertension, total cholesterol, TG, LDL, HDL, and fasting glucose. RESULTS: Data showed a significant association between hs-CRP concentration level and the severity of atherosclerosis (p < 0.01). Univariate analysis showed that fasting plasma glucose, triglyceride, and BMI were significantly positively correlated with hs-CRP levels. Whereas, HDL cholesterol was negatively correlated with hs-CRP levels. Multivariate regression analysis using model 1 and 2, showed that in determining hs-CRP levels, triglyceride and BMI were taking a big role. CONCLUSION: Hs-CRP correlates with extent of atherosclerosis, and high triglyceride and BMI is closely associated with high hs-CRP levels in patients with dyslipidemia.Keywords
This publication has 15 references indexed in Scilit:
- High-sensitivity C-reactive protein and exercise-induced changes in subjects suspected of coronary artery diseaseJournal of Inflammation Research, 2014
- Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection StudyCirculation, 2012
- Low-density lipoprotein cholesterol and risk of coronary heart disease among Japanese men and women: The Circulatory Risk in Communities Study (CIRCS)Preventive Medicine, 2011
- C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection StudyThe Lancet, 2011
- High-Sensitivity C-Reactive Protein Predicts Cardiovascular Risk in Diabetic and Nondiabetic Patients: Effects of Insulin-Sensitizing Treatment with PioglitazoneJournal of Diabetes Science and Technology, 2010
- Circulating markers of inflammation and atherosclerosisAtherosclerosis, 2003
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003
- Cytomegalovirus Seropositivity and C-Reactive Protein Have Independent and Combined Predictive Value for Mortality in Patients With Angiographically Demonstrated Coronary Artery DiseaseCirculation, 2000
- C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectorisEuropean Heart Journal, 2000
- The new paradigm for coronary artery disease: altering risk factors, atherosclerotic plaques, and clinical prognosis.1996